Amazon Pharmacy now offers GLP-1 weight-loss drugs like Wegovy and Zepbound to eligible Medicare patients for $50 a month, a drastic price cut from $1,200-$1,500. This move, part of the Medicare GLP-1 Bridge Program, aims to improve access for millions by automating enrollment and offering same-day delivery without Prime membership. CVS and Walmart are also lowering prices and expanding access, intensifying competition. The program covers drug costs for obese patients under Medicare, potentially saving customers $300 million and reshaping the weight-loss drug market.
The global smart TV market is projected to grow from $259.51 billion in 2025 to $923.12 billion by 2035, at a CAGR of 13.53%. This growth is fueled by the rise of OTT streaming platforms like Netflix and Disney+, widespread 5G and fiber internet acce...
Vanguard's Total Stock Market ETF (VTI) charges the same low fee as its S&P 500 ETF (VOO) but has consistently underperformed it over 1, 5, and 10 years. Although VTI holds around 3,600 stocks, its market-cap weighting means the top five tech giants ...
Amazon and Walmart are advancing integrated retail systems combining AI, advertising, product discovery, payments, and delivery to streamline the shopping experience. Walmart's recent acquisition of Vibe.co enhances its connected-TV advertising linke...
The ProShares UltraPro QQQ ETF (TQQQ) is recommended as a buy due to strong earnings reports from major hyperscalers like Amazon, Microsoft, and Google. These companies are accelerating revenue and capital expenditures, particularly driven by AI and ...
Lumen Technologies is advancing its multi-cloud strategy by partnering with Amdocs to modernize its enterprise service orchestration and order management platform on Amazon Web Services (AWS). This initiative builds on previous migrations to Google C...
